These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2829716)

  • 1. Computer automated structure evaluation of quinolone antibacterial agents.
    Klopman G; Macina OT; Levinson ME; Rosenkranz HS
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1831-40. PubMed ID: 2829716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
    Domagala JM; Hanna LD; Heifetz CL; Hutt MP; Mich TF; Sanchez JP; Solomon M
    J Med Chem; 1986 Mar; 29(3):394-404. PubMed ID: 3005575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Substituted 7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8- difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids. New quantitative structure-activity relationships at N1 for the quinolone antibacterials.
    Domagala JM; Heifetz CL; Hutt MP; Mich TF; Nichols JB; Solomon M; Worth DF
    J Med Chem; 1988 May; 31(5):991-1001. PubMed ID: 2834557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-Ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4- dihydro-4-oxo-3-quinoline-carboxylic acid. New quinolone antibacterial with potent gram-positive activity.
    Domagala JM; Heifetz CL; Mich TF; Nichols JB
    J Med Chem; 1986 Apr; 29(4):445-8. PubMed ID: 3007757
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mechanism of action of quinolones].
    Smith JT
    Infection; 1986; 14 Suppl 1():S3-15. PubMed ID: 2420724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular docking, discovery, synthesis, and pharmacological properties of new 6-substituted-2-(3-phenoxyphenyl)-4-phenyl quinoline derivatives; an approach to developing potent DNA gyrase inhibitors/antibacterial agents.
    Alagumuthu M; Arumugam S
    Bioorg Med Chem; 2017 Feb; 25(4):1448-1455. PubMed ID: 28094220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of substituted oxadiazoles as a novel scaffold for DNA gyrase inhibitors.
    Jakopin Ž; Ilaš J; Barančoková M; Brvar M; Tammela P; Sollner Dolenc M; Tomašič T; Kikelj D
    Eur J Med Chem; 2017 Apr; 130():171-184. PubMed ID: 28246042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 3-fluoro-6-methoxyquinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV.
    Mitton-Fry MJ; Brickner SJ; Hamel JC; Barham R; Brennan L; Casavant JM; Ding X; Finegan S; Hardink J; Hoang T; Huband MD; Maloney M; Marfat A; McCurdy SP; McLeod D; Subramanyam C; Plotkin M; Reilly U; Schafer J; Stone GG; Uccello DP; Wisialowski T; Yoon K; Zaniewski R; Zook C
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3353-3358. PubMed ID: 28610977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gyrase inhibitor].
    Forth W
    Klin Wochenschr; 1985 Oct; 63(19):1036-9. PubMed ID: 2999503
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative antibacterial activity of new quinolone-carboxylic acid derivatives.
    Mitsuhashi S
    Rev Infect Dis; 1988; 10 Suppl 1():S27-31. PubMed ID: 3347811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and anti-staphylococcal activity of novel bacterial topoisomerase inhibitors with a 5-amino-1,3-dioxane linker moiety.
    Li L; Okumu A; Dellos-Nolan S; Li Z; Karmahapatra S; English A; Yalowich JC; Wozniak DJ; Mitton-Fry MJ
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2477-2480. PubMed ID: 29871847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrepancy between the antibacterial activities and the inhibitory effects on Micrococcus luteus DNA gyrase of 13 quinolones.
    Fu KP; Grace ME; McCloud SJ; Gregory FJ; Hung PP
    Chemotherapy; 1986; 32(6):494-8. PubMed ID: 3026740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV.
    Mitton-Fry MJ; Brickner SJ; Hamel JC; Brennan L; Casavant JM; Chen M; Chen T; Ding X; Driscoll J; Hardink J; Hoang T; Hua E; Huband MD; Maloney M; Marfat A; McCurdy SP; McLeod D; Plotkin M; Reilly U; Robinson S; Schafer J; Shepard RM; Smith JF; Stone GG; Subramanyam C; Yoon K; Yuan W; Zaniewski RP; Zook C
    Bioorg Med Chem Lett; 2013 May; 23(10):2955-61. PubMed ID: 23566517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.
    Wolfson JS; Hooper DC
    Antimicrob Agents Chemother; 1985 Oct; 28(4):581-6. PubMed ID: 3000292
    [No Abstract]   [Full Text] [Related]  

  • 15. Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative Bacteria.
    Skepper CK; Armstrong D; Balibar CJ; Bauer D; Bellamacina C; Benton BM; Bussiere D; De Pascale G; De Vicente J; Dean CR; Dhumale B; Fisher LM; Fuller J; Fulsunder M; Holder LM; Hu C; Kantariya B; Lapointe G; Leeds JA; Li X; Lu P; Lvov A; Ma S; Madhavan S; Malekar S; McKenney D; Mergo W; Metzger L; Moser HE; Mutnick D; Noeske J; Osborne C; Patel A; Patel D; Patel T; Prajapati K; Prosen KR; Reck F; Richie DL; Rico A; Sanderson MR; Satasia S; Sawyer WS; Selvarajah J; Shah N; Shanghavi K; Shu W; Thompson KV; Traebert M; Vala A; Vala L; Veselkov DA; Vo J; Wang M; Widya M; Williams SL; Xu Y; Yue Q; Zang R; Zhou B; Rivkin A
    J Med Chem; 2020 Jul; 63(14):7773-7816. PubMed ID: 32634310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-generation 4,5,6,7-tetrahydrobenzo[
    Lamut A; Skok Ž; Barančoková M; Gutierrez LJ; Cruz CD; Tammela P; Draskovits G; Szili PÉ; Nyerges Á; Pál C; Molek P; Bratkovič T; Ilaš J; Zidar N; Zega A; Enriz RD; Kikelj D; Tomašič T
    Future Med Chem; 2020 Feb; 12(4):277-297. PubMed ID: 32043377
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclothialidine and its congeners: a new class of DNA gyrase inhibitors.
    Goetschi E; Angehrn P; Gmuender H; Hebeisen P; Link H; Masciadri R; Nielsen J
    Pharmacol Ther; 1993 Nov; 60(2):367-80. PubMed ID: 8022866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the dynamic quantitative structure-activity relationship method for modeling antibacterial activity of quinolone derivatives.
    Kamenska V; Mekenyan O; Sterev A; Nedjalkova Z
    Arzneimittelforschung; 1996 Apr; 46(4):423-8. PubMed ID: 8740092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International experiences with ofloxacin, a new quinolone.
    Mitsuhashi S
    Infection; 1986; 14 Suppl 4():S223-5. PubMed ID: 3028965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, Docking Studies, and In Vitro Evaluation of Some Novel Thienopyridines and Fused Thienopyridine-Quinolines as Antibacterial Agents and DNA Gyrase Inhibitors.
    Mohi El-Deen EM; Abd El-Meguid EA; Hasabelnaby S; Karam EA; Nossier ES
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31658631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.